Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01451996 · ClinicalTrials.gov registry record · Phase 4
The Efficacy of Claritin in Healthy Subjects
A Phase 4 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 340
- Enrollment target
NCT01451996 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 340 participants.
The verdict
NCT01451996, a Phase 4 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 340 participants
- Enrollment target
Study Summary
The primary goal of this study is to examine determinants of the efficacy of Claritin.
Interventions
- DRUG Claritin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01451996
The ClinicalTrials.gov registry entry for NCT01451996 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Claritin is the first listed.
NCT01451996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01451996 about?
NCT01451996 is a clinical study titled "The Efficacy of Claritin in Healthy Subjects". The primary goal of this study is to examine determinants of the efficacy of Claritin.
What is the current status of trial NCT01451996?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 340 participants. The study started on 2011-10. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01451996?
The interventions under investigation include: Claritin (DRUG).
Who is sponsoring clinical trial NCT01451996?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.